Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.

OBJECTIVES To determine whether peak blood procalcitonin (PCT) measured within 48 hours of pediatric intensive care unit (PICU) admission can differentiate severe bacterial infections from sterile inflammation and viral infection and identify potential subgroups of PICU patients for whom PCT may not have clinical utility. STUDY DESIGN This was a retrospective, observational study of 646 critically ill children who had PCT measured within 48 hours of admission to an urban, academic PICU. Patients were stratified into 6 categories by infection status. We compared test characteristics for peak PCT, C-reactive protein (CRP), white blood cell count (WBC), absolute neutrophil count (ANC), and % immature neutrophils. The area under the receiver operating characteristic curve was determined for each biomarker to discriminate bacterial infection. RESULTS The area under the receiver operating characteristic curve was similar for PCT (0.73, 95% CI 0.69, 0.77) and CRP (0.75, 95% CI 0.71, 0.79; P = .36), but both outperformed WBC, ANC, and % immature neutrophils (P < .01 for all pairwise comparisons). The combination of PCT and CRP was no better than either PCT or CRP alone. Diagnostic patterns prone to false-positive and false-negative PCT values were identified. CONCLUSIONS Peak blood PCT measured close to PICU admission was not superior to CRP in differentiating severe bacterial infection from viral illness and sterile inflammation; both PCT and CRP outperformed WBC, ANC, and % immature neutrophils. PCT appeared especially prone to inaccuracies in detecting localized bacterial central nervous system infections or bacterial coinfection in acute viral illness causing respiratory failure.

[1]  C. Rey,et al.  Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children , 2007, Intensive Care Medicine.

[2]  P. Sánchez,et al.  Prospective Surveillance of Antibiotic Use in the Neonatal Intensive Care Unit: Results From the SCOUT Study , 2015, The Pediatric infectious disease journal.

[3]  J. Quenot,et al.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome , 2009, Critical care.

[4]  J. Deis,et al.  Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency Department , 2010, Pediatric emergency care.

[5]  K. Becker,et al.  Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations , 2008, Critical care medicine.

[6]  J. Garnacho-Montero,et al.  Antibiotic de-escalation in the ICU: how is it best done? , 2015, Current opinion in infectious diseases.

[7]  J. Coste,et al.  Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. , 1999, The Pediatric infectious disease journal.

[8]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[9]  D. Pregibon Logistic Regression Diagnostics , 1981 .

[10]  C. Cubells,et al.  Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker , 2003 .

[12]  J. Casado‐flores,et al.  Serum procalcitonin in children with suspected sepsis: A comparison with C-reactive protein and neutrophil count* , 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[13]  Arun Chopra,et al.  Procalcitonin Use in a Pediatric Intensive Care Unit , 2014, The Pediatric infectious disease journal.

[14]  Sameer J. Patel,et al.  Antimicrobial stewardship in the NICU. , 2014, Infectious disease clinics of North America.

[15]  J. Steiner,et al.  Chart reviews in emergency medicine research: Where are the methods? , 1996, Annals of emergency medicine.

[16]  U. Ruttimann,et al.  PRISM III: an updated Pediatric Risk of Mortality score. , 1996, Critical care medicine.

[17]  D. Pittet,et al.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.

[18]  L. M. Srivastava,et al.  Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. , 2015, Journal of critical care.

[19]  D. Goodman,et al.  Red Blood Cell Distribution Width as a Pragmatic Marker for Outcome in Pediatric Critical Illness , 2015, PloS one.

[20]  M. Assicot,et al.  High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.

[21]  Jeffrey L. Greenwald,et al.  Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. , 2011, Archives of internal medicine.

[22]  R. Khemani,et al.  Procalcitonin to Detect Suspected Bacterial Infections in the PICU , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[23]  S. Tibby,et al.  Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count , 1999, Archives of disease in childhood.

[24]  J. Lacroix,et al.  Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[25]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[26]  P. Schuetz,et al.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future , 2011, BMC medicine.

[27]  F. Shann,et al.  PIM2: a revised version of the Paediatric Index of Mortality , 2003, Intensive Care Medicine.

[28]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[29]  B. Hoen,et al.  Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[31]  J. Pugin,et al.  Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. , 2008, American journal of respiratory and critical care medicine.

[32]  J. Bouyer,et al.  Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.

[33]  Andrew Dauber,et al.  Procalcitonin in Young Febrile Infants for the Detection of Serious Bacterial Infections , 2008, Pediatrics.

[34]  D. Gerding,et al.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.

[35]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[36]  P. Schlattmann,et al.  Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis , 2013, Critical Care.